Medicinal chemistry – Page 57
-
-
Research
Simple sensor can spot cancer markers in minutes
Test can rapidly detect mutant tumour nucleic acids in boost for personalised medicine
-
OpinionMagic molecule modifiers
Late stage functionalisation can seem supernaturally powerful, says Derek Lowe – if you’ve got the nerve to try it
-
ResearchTaking the lead on drug discovery
Making compounds that promise to become useful drugs has just become a little easier
-
ResearchMalaria drug could cash in on green chemistry
Minimising acid and solvent toxicity brings surprising benefits in artemisinin production
-
NewsRoadmap to reward pharma for creating new antibiotics unveiled
Report recommends large up-front payments and an innovation fund for blue skies research to tackle microbial resistance
-
ReviewVenoms to drugs: venom as a source for the development of human therapeutics
Defanging chemistry
-
NewsScientists call for ban on fluorinated chemicals
The Madrid Statement, signed by 200 scientists, urges consumers to avoid PFAS-containing products
-
ResearchZombie cells may rise up to kill infections
Bacteria killed by silver may act as vessels for the metal to kill other pathogens
-
FeatureImaging the future
Doctors and pharmaceutical companies are beginning to open their eyes to the power of mass spectrometry imaging, finds Nina Notman
-
ResearchSiRNA treatment cures Ebola in monkeys
Researchers perform the first successful trial for a drug against the current strain of Ebola
-
ResearchHydrogel with a basic instinct for drug delivery
Gel that releases naproxen in alkaline surroundings is promising step toward relieving drug’s side effects
-
ResearchSilicon chip spots dangerous pathogens in human blood
Silicon wafer doped with silver nanoparticles can rapidly identify E. coli in blood
-
FeatureBig problems with little particles?
There is a risk that poor toxicology studies could start undermining the success of nanomaterials, reports Elinor Hughes
-
ResearchDNA test colours in BRCA1 gene
Rolling circle amplification aids femtomolar sensitivity for gene linked with breast cancer
-
FeatureCombating rare diseases
Developing drugs for treating rare diseases isn’t always financially viable. Clare Sansom looks at some recent success stories
-
Opinion'What gets measured gets done'
Measuring R&D productivity is a thorny issue. Dennis Lendrem urges the pharmaceutical industry to learn from its mistakes.
-
OpinionAnalogues by catalogue
Buying in screening compounds directly feels like cutting out the synthetic chemist middleman, says Derek Lowe
-
Business23andMe jumps into drug R&D
Gene profiling firm aims to capitalise on its databank of genetic information to discover new drugs